🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ellen Burgess

University of New Mexico

ORCID: 0000-0002-6075-4512

Also affiliated with New Mexico Cancer Center, UNM Comprehensive Cancer Center

MedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease”.

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal(2022)10.1093/ckj/sfac234

N/A

2.0DataRank · unranked

102 citations

Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos +12 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

Patient, provider, and nurse preferences regarding patient-reported outcomes (PRO) and side effect management during cancer treatment of minority, rural and economically disadvantaged patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18652

N/A

0DataRank · unranked

0 citations

Karen Quezada, Ellen Burgess, Mikaela Kosich, Shoshana Adler Jaffe, Dolores D. Guest +5 more